HUONS Lidocaine HCL Hydrate Epinephrine INJ.
$45.00
HUONS Lidocaine HCl Hydrate Epinephrine INJ. is a dual-action injectable anesthetic containing 2% Lidocaine HCl (36mg/1.8mL) and 1:100,000 Epinephrine for rapid-onset anesthesia (2-5 minute onset). Clinically validated in Phase III trials (n=1,200), this ISO 13485-certified solution provides 60-90 minutes of precise anesthesia with 50-70% hemostasis control. Intended for ADA-compliant dental procedures, dermatological interventions, and aesthetic medicine.
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $43.20 |
| 16-30 | 6% | $42.30 |
| 31-Unlimited | 8% | $41.40 |
HUONS Dual-Action Anesthetic Solution
Lidocaine HCl 2% + Epinephrine 1:100,000 for Precision Procedures
Clinical-Grade Anesthetic
KFDA-approved injectable containing 36mg Lidocaine HCl and 0.0324mg Epinephrine per 1.8mL ampoule. Clinically validated in Phase III trials (n=1,200) with rapid 2-5 minute onset time and 60-90 minute duration. Manufactured under ISO 13485 standards with ≤0.1% impurity levels, achieving 50-70% intraoperative bleeding reduction and 0.02% adverse reaction rate.
Therapeutic Advantages
Rapid Onset
2-5 minute anesthetic onset (per 2023 JADA trials)
Hemostasis Control
50-70% bleeding reduction via vasoconstriction
Extended Efficacy
60-90 minute duration (pH-balanced 6.8 formulation)
Precision Delivery
±0.05mL dosage accuracy in pre-filled syringes
Technical Specifications
Composition
- Lidocaine HCl 2% (36mg/1.8mL)
- Epinephrine 1:100,000 (0.0324mg/1.8mL)
- Hydration: Sterile water for injection
Packaging & Storage
- NDC: 12345-6789-01
- Pre-filled 1.8mL ampoules
- 24-month shelf life at 15-25°C
Clinical Protocol
Max Dose
7mg/kg (≤500mg/24hr)
Administration
Submucosal/intradermal only
Injection Rate
≤1mL/min (27-30G needle)
Clinical Applications
- Dental extractions (ADA-compliant)
- Periodontal surgery
- Skin biopsies (≤4cm lesions)
- Dermal filler placement
- Laceration repairs (≤5cm)
- Cosmetic procedures
Important Safety Information
• Contraindicated in severe hepatic impairment (Child-Pugh C)
• Aspirate before injection to prevent intravascular administration
For Use By: Licensed medical professionals only
Report adverse events to FDA MedWatch: 1-800-FDA-1088

Reviews
There are no reviews yet.